Walgreens Boots Alliance (NASDAQ: WBA) reported third quarter 2020 earnings results today.
Sales increased 0.1% year-over-year to $34.6 billion. Sales growth was 1.2% on a constant currency basis, led by Retail Pharmacy USA comparable sales growth of 3%. The adverse impact of COVID-19 on sales was approx. $700-750 million, with the majority of the impact related to the Retail Pharmacy International division.
Stay tuned here for WBA Q3 2020 Earnings Transcript
Net loss attributable to WBA was $1.7 billion, or $1.95 per share, compared to earnings of $1 billion, or $1.13 per share, a year ago. Adjusted net earnings attributable to WBA decreased 45.9% to $723 million and adjusted EPS fell 43.8% to $0.83.
For fiscal 2020, adjusted EPS is expected to be $4.65 to $4.75, including estimated adverse COVID-19 impacts of $1.03-1.14 per share.
The board of directors declared a quarterly dividend of 46.75 cents per share, up 2.2%. The dividend is payable on September 11, 2020 to stockholders of record as of August 19, 2020, and raises the annual rate from $1.83 per share to $1.87 per share. The company is also suspending activity under its share repurchase program.
Most Popular
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain
eBay (EBAY): A few factors that helped drive growth in Q3 2024
Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to
